• Side effects and sub-types: 20 years of understanding childhood cancer

  • Sep 6 2022
  • Length: 23 mins
  • Podcast

Side effects and sub-types: 20 years of understanding childhood cancer

  • Summary

  • Cancer Research Matters, a new Podcast from Cancer Research UK featuring some of the incredible researchers behind cancer research. The idea is to drive and provoke conversation around cancer science, how it shapes our understanding of the disease and the challenges we face as we develop therapies.

    The first series focusses on the 20th anniversary of CRUK – we’ll be winding back the clock on some of the great discoveries and breakthroughs made in the past two decades and asking some leading names where they think we’ll be in another 20 years.


    This episode features Professor Richard Gilbertson. Richard is a paediatric oncology clinician scientist and is the Director of the Cancer Research UK Cambridge Centre. He has dedicated his career to understanding childhood brain tumours and is perhaps known best for his work identifying different types of medulloblastoma and ependymoma – two of the most common kinds of childhood brain tumour.

    He talks about the challenges and successes of the childhood cancer research community, how he sees the future of the field and some of the incredible breakthroughs his lab has made on childhood brain cancers.


    Further reading

    WNT signalling and brain cancer

    https://link.springer.com/article/10.1007/s00401-012-0958-8

    https://www.sciencedirect.com/science/article/pii/S1535610816300551

    Read about CRUK’s data strategy

    https://news.cancerresearchuk.org/2022/07/07/joining-the-dots-how-our-new-research-data-strategy-will-unlock-the-power-of-big-data/

    See the data strategy

    https://www.cancerresearchuk.org/sites/default/files/cancer_research_uk_-_research_data_strategy.pdf


    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
activate_samplebutton_t1

What listeners say about Side effects and sub-types: 20 years of understanding childhood cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.